LTS Lohmann Therapies-Systeme AG, IIS Innovative Injektions-Systeme

Booth number 1901-7

www.ltslohmann.de

About us

Under the guidance of our parent company LTS Lohmann Therapie-Systeme AG we research and develop innovative injection systems and have specialized in two technologies: Needle-free Injections (NFI) and Micro Array Patches (MAP).

These technologies use the skin to deliver active ingredients like biologicals, pharmaceuticals and vaccines directly into the body and offer therefore a convenient alternative to injections and infusions. MAP-technology combines benefits of transdermal therapeutic systems with innovative microneedles.

Prefilled, single use, disposable and cost efficient, NFIs and MAPs provide the option for patient convenient self-administration.

Tailor made development of NFI and MAP with many differentiating advantages is conducted in our state-of-the-art R&D Centre located in Andernach, Germany, allowing GMP manufacturing of clinical supplies.

Products and services

Under the guidance of our parent company LTS Lohmann Therapie-Systeme AG we research and develop innovative injection systems and have specialized in two technologies: Needle-free Injections (NFI) and Micro Array Patches (MAP).

These technologies use the skin to deliver active ingredients like biologicals, pharmaceuticals and vaccines directly into the body and offer therefore a convenient alternative to injections and infusions. MAP-technology combines benefits of transdermal therapeutic systems with innovative microneedles.

Prefilled, single use, disposable and cost efficient, NFIs and MAPs provide the option for patient convenient self-administration.

Tailor made development of NFI and MAP with many differentiating advantages is conducted in our state-of-the-art R&D Centre located in Andernach, Germany, allowing GMP manufacturing of clinical supplies.

IIS Microarray-Patch (MAP) and IIS Needlefree Injection (NFI)

As the global marketleader in transdermal therapeutic systems, LTS LohmannTherapie-Systeme AG is laying the foundation for new and improved therapy options. LTS researches and develops advancing emerging drug delivery technologies, including Needle-free Injections (NFI) and Micro Array Patches (MAP)

Address
LTS Lohmann Therapies-Systeme AG, IIS Innovative Injektions-Systeme
Lohmannstr. 2
56626 Andernach
Germany

Phone: +49 2632 992797
Internet: www.ltslohmann.de
E-mail: Send message

Contact person

Dr. Stefan Henke
Managing Director IIS
Phone: +40 2632 992797
E-mail: Send message

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection